Fresh out of stealth mode, Luna Health, founded by three diabetes device stalwarts—Sean Saint, John Sjölund, and Jon Brilliant—is preparing for a US trial of its automated insulin delivery system, a first-of-its-kind, nighttime-only on-body device that Sjölund says will make the experience of automated insulin delivery “much simpler and more accessible to many more people.”
People with diabetes, particularly those who must take insulin, face a high daily burden to effectively manage their disease, and many struggle to maintain optimal blood sugar levels throughout the day and night. Start-up Luna Health Inc. is working to reduce that burden and improve outcomes with a unique, nighttime-only insulin delivery system.
Luna’s system, which integrates with a continuous glucose monitor (CGM), is a small on-body insulin delivery device that automatically delivers micro doses of insulin during the night only when needed. Daytime insulin dosing with an insulin pen remains unchanged. The concept is much simpler and more cost-effective than existing 24-hour automated insulin delivery (AID) systems, says Luna CEO John Sjölund, and it is expected to appeal to a broader range of diabetes patients, bringing a tech-enabled solution for improved glucose control to the 90% of insulin users who are unable or unwilling to use a traditional insulin pump.